Caitlin John’s Amedisys AMED Stock Holding History

Caitlin John’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2	Closed	-$182	–	159
2024 Q4	$182	Hold	2	–	–	﹤0.01%	820
2024 Q3	$181	Sell	2 -2	-50%	-$195	﹤0.01%	808
2024 Q2	$367	Buy	4 +2	+100%	+$186	﹤0.01%	787
2024 Q1	$184	Sell	2 -6	-75%	-$562	﹤0.01%	843
2023 Q4	$760	Buy	+8	New	+$747	﹤0.01%	782

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Caitlin John's AMED Position: Q1 2025 in Review

Caitlin John sold out of Amedisys (AMED) in Q1 2025, closing a stake of 2 shares — an estimated $182 sold.

Caitlin John first reported a position in AMED in Q4 2023 and held it in 5 quarters. The position peaked at $760 in Q4 2023. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

Caitlin John reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
Caitlin John sold 2 Amedisys shares in Q1 2025, an estimated $182.
Caitlin John first reported a position in Amedisys in Q4 2023 and held it in 5 quarters.
Caitlin John's Amedisys position peaked at $760 in Q4 2023.
304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on Caitlin John's 13F filing for Q1 2025, filed 14 May 2025.